Patents by Inventor James E. Fish

James E. Fish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Consumer-ready pyrotechnic display system and control module therefor
    Patent number: 10260846
    Abstract: A consumer-ready, disposable pyrotechnic display system includes a pyrotechnic module and a control module. The pyrotechnic module includes a mounting substrate, electrically ignitable pyrotechnic devices, and electrical conductors connected to the pyrotechnic devices and disposed beneath the mounting substrate. The control module includes a housing having an upper surface and a bottom surface on which electrical contacts are disposed; and a processor, a memory, a power supply, and a transceiver within the housing. The electrical conductors are connected to the electrical contacts prior to receipt by the consumer. When the transceiver receives a signal from a remote device (such as a cellular telephone), the processor ignites each of the electrical conductors in a sequence programmed into the memory of the control module.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: April 16, 2019
    Inventor: James E. Fish
  • Diagnosing asthma patients predisposed to adverse beta-agonist reactions
    Publication number: 20020119474
    Abstract: The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of &bgr;-agonists. The invention also provides kits useful for this purpose.
    Type: Application
    Filed: November 21, 2001
    Publication date: August 29, 2002
    Inventors: Jeffrey M. Drazen, Vern Chinchilli, Richard Martin, Robert Lemanske, Jean G. Ford, James E. Fish, Homer Boushey
  • Diagnosing asthma patients predisposed to adverse .beta.-agonist reactions
    Patent number: 6156503
    Abstract: The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of .beta.-agonists. The invention also provides kits useful for this purpose.
    Type: Grant
    Filed: March 3, 1997
    Date of Patent: December 5, 2000
    Assignees: The Regents of the University of California, The Trustees of Columbia University in the City of New York, The Penn State Research Foundation, National Jewish Medical and Research Center, Wisconsin Alumni Research Center, Thomas Jefferson University, Brigham and Women's Hospital
    Inventors: Jeffrey M. Drazen, Vern Chinchilli, Richard Martin, Robert Lemanske, Jean G. Ford, James E. Fish, Homer Boushey